All News
#Blinded by results? 😊
#Ocular #involvement in #GPA
👇
Helped by #rituximab
👁️ #GPA
Difficult
Proptosis
Pseudotumour
Conjunctivitis
Scleritis
Vasculitis
Ocular muscles - diplopia
Small case series ‘author defined’ remission in
80% 👍 #RTX
#abst0726 @rheumnow #ACR24 https://t.co/GHptelOTyv
Janet Pope Janetbirdope ( View Tweet)
If high +ANA and NO #rheumatic #disease LOOK 👀 at #LIVER #Autoimmune #hepatitis And #alcoholic #liver #dx #ACRBest #ACR24 @rheumnow abst#0627 https://t.co/EVLUyvpBfD
Links:
Janet Pope Janetbirdope ( View Tweet)
Improved fertility in women with RA when treated with a Treat-to-Target (T2T) approach aimed at remission.
Key findings:
- Shorter time to pregnancy (TTP) in PreCARA cohort (84 days) vs. PARA cohort (196 days).
- Increased TNF-inhibitor use and lower NSAID/prednisone use in the… https://t.co/YyD2lpXVRC https://t.co/LH5LMOH8al
Links:
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
@ACRheumDC
Check out the ACR policy position statements
Created by volunteer-led, non-partisan group of GAC committee - changes based on the needs of the ACR members
@cdowneymd
https://t.co/oAFfYUct4y
@RheumNow #ACR24 https://t.co/MmVd8XYs0j
Links:
Eric Dein ericdeinmd ( View Tweet)
Half of the respondents chose #IL17i for #psoriatic #arthritis #PsA Rx for #Achilles #tendonitis
Interesting as lots
Of data
On #enthesitis wIL23i
Likely all
Effective #PsA Rx helps #tenosynovitis
some have
➡️ data on #efficacy
⬆️ bio rationale
#ACR24 @RheumNow @ACRheum https://t.co/wzefjsfdaj
Janet Pope Janetbirdope ( View Tweet)
If you are not at the table, you are on the menu
https://t.co/c4anIn3aue
@cdowneymd @ACRheumDC
Join a committee
RheumPAC
Write a letter
Write a post card at ACR Hub at #ACR24
Advocacy office hours with ACR staff
#Act4Arthritis & Advocacy 101 on Cap Hill
@RheumNow https://t.co/bpilydxEpB
Links:
Eric Dein ericdeinmd ( View Tweet)
The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarthritis patients treated with IL-17A (secukinumab) or TNF inhibitors over 2 years.
Key findings:
- New syndesmophytes: 18.2% (SEC 150 mg), 15.8% (SEC 300 mg),… https://t.co/jke6OHdPjZ
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
The future use of a panel of immunological urinary biomarkers as a liquid biopsy for the management of lupus nephritis. Plenary Abstr#1642 @RheumNow #ACR24 https://t.co/waSRVd7FV7
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
@LennMcD @ACRheumDC
Current congress (118th) - very tight margins, paralyzed by the ‘24 elections. Now in lame duck
Many ACR policies made into bills - PA, step rx, copay accumulator, workforce, loan repayment, incr Rx transparency
Needs to be passed into law
@RheumNow #ACR24 https://t.co/1elEUiUAmh
Eric Dein ericdeinmd ( View Tweet)
@DrLauraCoates presented Sex differences in clinical presentations of PsA:
-Women present >polyarthritis, enthesitis and worse PROs which translates to ⬆️ DAPSAs in spite of less Rx progression.
-Men more oligoarthritis, axial involvement, higher skin disease.
#ACR24… https://t.co/iapZF0nZWX https://t.co/jZ79WfxZwh
Links:
Adela Castro AdelaCastro222 ( View Tweet)
🔥Sex matters in PsA
🔑Differences in :
➡️clinical phenotypes
➡️radiographic progression
➡️disease impact
➡️pt perception of disease
➡️response to Rx
#ACR24 @RheumNow https://t.co/iOXQmoxgp0
Caoilfhionn Connolly CaoilfhionnMD ( View Tweet)
Dr @andreafava presents their noninvasive biomarker panel that predicted the probability of histologically active LN.
Panel outperformed UPCR, C3, C4 & antidsDNA.
Aid in clinical-decision making? Lots of potential for monitoring tx response.
@Rheumnow #ACR24 abs1642
#ACRbest https://t.co/C7ZNdvbIQ7
Links:
sheila RHEUMarampa ( View Tweet)
@LennMcD
@ACRheumDC
Many ACR priorities in bills, needs to be passed in law
Victories:
Incr NIH biomedical research funding, added to DoD funds
Medicare reimbursem and telehealth needs addressed by lame duck congress
Get involved, reach out, write letters
@RheumNow #ACR24 https://t.co/7oCvUFWpx4
Links:
Eric Dein ericdeinmd ( View Tweet)
Impressive Plenary @andreafava just finished Novel urine protein panel id 12 proteins that predict NIH activity on renal bx better than existing options Improving at 3 mos predicts response at 1 year Could reduce biopsies / modulate tx! #ACR24 @RheumNow Abstr#1642 #ACRbest https://t.co/Gi6u6hAGzj
Links:
Mike Putman EBRheum ( View Tweet)
"We look forward to Carol Langfords upcoming leadership at ACR and its newfound focus on ANCA vasculitis as the most important disease" 😆😂
-Phil Seo
#ACR24 @RheumNow
Mike Putman EBRheum ( View Tweet)
A study presents a novel urinary biomarker panel that predicts histologically active lupus nephritis (LN) with high accuracy.
Key findings:
- AUC of 90% for predicting NIH Activity Index > 2, outperforming traditional biomarkers.
- Identified 12 critical proteins linked to… https://t.co/6ZhqNaxpQM
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
The 3-4-5 rule for positive MRI in axSpA remains.
The MRI lesion cut-offs demonstrated high performance across different features of axSpA (PsO, AAU,IBD).
Deep fat and deep sclerosis high specificity for axSpA.
#Abst0821 #ACR24 @RheumNow https://t.co/4JM5MHrB8z
Links:
Adela Castro AdelaCastro222 ( View Tweet)
Starting soon:
Room 152A
@ACRheumDC @cdowneymd @BelindaBirnbaum
What does the election and current political changes mean for rheumatology?
How does ACR play a role in supporting you? What are the easy steps you can do?
#ACR24 @RheumNow https://t.co/jTtk80RdqI
Eric Dein ericdeinmd ( View Tweet)
Thrilled to have my abstract accepted for poster presentation at #ACR24 with @rheumarhyme
Drop by abs1314 to know more 🤓
#HPEd #educator #telerheumatology
@Rheumnow https://t.co/j2rZLGm7lA
sheila RHEUMarampa ( View Tweet)
Managing DMARDs in pregnancy. Curbside consults by Lisa Sammaritano @RheumNow #ACR24 https://t.co/FQrLNz4yCz
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
